NL930097I2 - Nieuwe oximen van erytromycine A, hun bereiding, hun toepassing als geneesmiddelen en farmaceutischepreparaten, die hen bevatten. - Google Patents

Nieuwe oximen van erytromycine A, hun bereiding, hun toepassing als geneesmiddelen en farmaceutischepreparaten, die hen bevatten.

Info

Publication number
NL930097I2
NL930097I2 NL930097C NL930097C NL930097I2 NL 930097 I2 NL930097 I2 NL 930097I2 NL 930097 C NL930097 C NL 930097C NL 930097 C NL930097 C NL 930097C NL 930097 I2 NL930097 I2 NL 930097I2
Authority
NL
Netherlands
Prior art keywords
erythromycin
medicines
preparation
pharmaceutical preparations
preparations containing
Prior art date
Application number
NL930097C
Other languages
English (en)
Dutch (nl)
Other versions
NL930097I1 (nl
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9237443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930097(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of NL930097I1 publication Critical patent/NL930097I1/nl
Publication of NL930097I2 publication Critical patent/NL930097I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NL930097C 1980-01-11 1993-06-25 Nieuwe oximen van erytromycine A, hun bereiding, hun toepassing als geneesmiddelen en farmaceutischepreparaten, die hen bevatten. NL930097I2 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8000566A FR2473525A1 (fr) 1980-01-11 1980-01-11 Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
NL930097I1 NL930097I1 (nl) 1993-10-01
NL930097I2 true NL930097I2 (nl) 1995-04-03

Family

ID=9237443

Family Applications (1)

Application Number Title Priority Date Filing Date
NL930097C NL930097I2 (nl) 1980-01-11 1993-06-25 Nieuwe oximen van erytromycine A, hun bereiding, hun toepassing als geneesmiddelen en farmaceutischepreparaten, die hen bevatten.

Country Status (25)

Country Link
US (1) US4349545A (en])
EP (1) EP0033255B1 (en])
JP (1) JPS56100799A (en])
KR (1) KR850000964B1 (en])
AU (1) AU537247B2 (en])
BG (1) BG61369B2 (en])
CA (1) CA1162535A (en])
CY (1) CY1319A (en])
DE (1) DE3165720D1 (en])
DK (1) DK157878C (en])
ES (1) ES8200702A1 (en])
FI (1) FI69473C (en])
FR (1) FR2473525A1 (en])
GR (1) GR73103B (en])
GT (1) GT198500080A (en])
HK (1) HK586A (en])
HU (1) HU187760B (en])
IE (1) IE50680B1 (en])
IL (1) IL61808A (en])
LU (1) LU88283I2 (en])
MY (1) MY8500984A (en])
NL (1) NL930097I2 (en])
OA (1) OA06719A (en])
PT (1) PT72331B (en])
ZA (1) ZA808108B (en])

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
DE3668894D1 (en) 1985-03-12 1990-03-15 Beecham Group Plc Erythromycin-derivate.
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
EP0260938B1 (en) 1986-09-18 1992-12-09 Taisho Pharmaceutical Co. Ltd Erythromycin a derivatives and method for preparing the same
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
DE69227713D1 (de) 1991-03-15 1999-01-14 Merck & Co Inc 9-Deoxo-9(Z)-hydroxyiminoerythromycin A und O-Derivate hiervon
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
ES2036472B1 (es) * 1991-10-01 1994-03-01 Prodesfarma Sa Procedimiento de obtencion de eritromicina 9-(0-((2-metoxietoxi)metil)oxima) (roxitromicina).
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
CA2189001A1 (en) * 1994-04-26 1995-11-02 Nobuhiro Narita Medicinal composition as a remedy for nonsmall cell lung cancer
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
PT102202B (pt) * 1998-09-10 2001-04-30 Hovione Sociedade Quimica S A Processo para a purificacao de roxitromicina
IN190782B (en]) * 1998-09-30 2003-08-23 Max India Ltd
EP1004591B1 (en) * 1998-11-24 2003-04-09 Max India Limited Process for preparing roxithromycin and derivatives thereof
KR20020070991A (ko) * 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
DK1280535T3 (da) 2000-01-11 2005-04-04 Teva Pharma Processer til fremstilling af clarithromycin polymorfer
HRP20020709A2 (en) * 2000-02-29 2004-12-31 Teva Pharma Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020991A2 (en) 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
AU2003271408B2 (en) * 2002-12-31 2008-07-17 Alembic Limited A process for the purification of roxithromycin
RU2222333C1 (ru) * 2003-03-06 2004-01-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с антибактериальной активностью и способ ее получения
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
ES2642287T3 (es) 2010-12-09 2017-11-16 Wockhardt Limited Compuestos cetólidos
KR101567658B1 (ko) 2011-03-01 2015-11-09 욱크하르트 리미티드 케톨리드 중간체의 제조 방법
JP5657834B2 (ja) 2011-03-22 2015-01-21 ウォックハート リミテッド ケトライド化合物の製造方法
CN102219816A (zh) * 2011-05-12 2011-10-19 浙江国邦药业有限公司 一种罗红霉素的纯化方法
PL222631B1 (pl) 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
CN104163840A (zh) * 2013-08-30 2014-11-26 郑州后羿制药有限公司 一种罗红霉素的精制方法
FR3049861A1 (fr) 2016-04-07 2017-10-13 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3869444A (en) * 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
ES434842A1 (es) * 1975-02-19 1976-12-01 Andreu Sa Dr Procedimiento para la preparacion de esteres de la oxima deeritromicina.
DE2515076A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue erythromycinderivate, deren salze und verfahren zu ihrer herstellung
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
FR2473525A1 (fr) 1981-07-17
JPS6237639B2 (en]) 1987-08-13
OA06719A (fr) 1982-06-30
IL61808A0 (en) 1981-01-30
IL61808A (en) 1986-12-31
KR830005258A (ko) 1983-08-03
ZA808108B (en) 1982-01-27
DK157878B (da) 1990-02-26
FI69473C (fi) 1986-02-10
CY1319A (en) 1986-03-28
KR850000964B1 (ko) 1985-07-02
IE810046L (en) 1981-07-11
AU537247B2 (en) 1984-06-14
FI810042L (fi) 1981-07-12
GR73103B (en]) 1984-02-02
ES498395A0 (es) 1981-11-01
GT198500080A (es) 1987-03-06
CA1162535A (fr) 1984-02-21
MY8500984A (en) 1985-12-31
US4349545A (en) 1982-09-14
EP0033255A1 (fr) 1981-08-05
HK586A (en) 1986-01-10
JPS56100799A (en) 1981-08-12
IE50680B1 (en) 1986-06-11
EP0033255B1 (fr) 1984-08-29
BG61369B2 (bg) 1997-06-30
FI69473B (fi) 1985-10-31
ES8200702A1 (es) 1981-11-01
DK7881A (da) 1981-07-12
PT72331A (fr) 1981-02-01
FR2473525B1 (en]) 1983-04-15
HU187760B (en) 1986-02-28
DK157878C (da) 1990-07-30
LU88283I2 (fr) 1994-09-09
NL930097I1 (nl) 1993-10-01
PT72331B (fr) 1982-07-23
AU6613181A (en) 1981-07-16
DE3165720D1 (en) 1984-10-04

Similar Documents

Publication Publication Date Title
NL930097I2 (nl) Nieuwe oximen van erytromycine A, hun bereiding, hun toepassing als geneesmiddelen en farmaceutischepreparaten, die hen bevatten.
NL930106I2 (nl) Ergolineverbindingen, hun bereiding en farmaceutische preparaten die ze bevatten.
NL191738C (nl) ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten.
NL930045I2 (nl) 7-Acylamino-3-vinylcefalosporanzuurderivaten, werkwijzen ter bereiding daarvan, farmaceutische preparaten die deze bevatten, hun uitgangsverbindingen en de bereiding daarvan.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL7810520A (nl) Nieuwe 2,6-diaminonebularinen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL960027I1 (nl) Nieuwe derivaten van 3.4.5-trihydroxypiperidine, werkwijzen ter bereiding ervan, hun toepassing en genees- en diervoedingsmiddelen, die deze bevatten.
NL154500B (nl) Werkwijze ter bereiding van 2-cyclohexeen-1-on-derivaten en van herbicide preparaten, die deze bevatten.
NL7409404A (nl) Fungiciden en preparaten die deze fungiciden bevatten.
NL7411047A (nl) Werkwijze ter bereiding van nieuwe pyrimidinen en van farmaceutische preparaten, die dergelij- ke pyrimidinen bevatten.
NL950014I2 (nl) Met sulfamoyl gesubstitueerde fenetylaminederivaten, de bereiding daarvan en farmaceutische preparaten, die deze derivaten bevatten.
NL193855B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
NL7803162A (nl) Nieuwe 1-aminoindaanderivaten, alsmede farmaceutische preparaten die deze bevatten.
NL930101I2 (nl) Gebruik van 3,3'-azo-bis-(6-hydroxybenzoëzuur) alseen medicijn en farmaceutische preparaten die dez e stof bevatten.
NL188645C (nl) 1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7804887A (nl) Bisamidine-verbindingen, hun bereiding, en farmaceuti- sche mengsels die hen bevatten.
NL192520B (nl) Gesubstitueerde tetrahydrofuranderivaten met anti-PAF-werking, werkwijze voor hun bereiding en farmaceutische preparaten die hen bevat.
NL7900966A (nl) Nieuwe 3-fenyltetrahydropyridine-derivaten en de zouten daarvan, werkwijze ter bereiding daarvan, de toepassing daarvan als geneesmiddelen en farmaceutische prepara- ten, die deze derivaten bevatten.
NL7902993A (nl) Nieuwe isochinolinederivaten, de bereiding ervan en farmaceutische preparaten, die de nieuwe isochinoline- derivaten bevatten.
NL188579C (nl) 3-(tetrazol-5-yl)-1-azaxanthonen, alsmede farmaceutische preparaten die deze verbindingen bevatten.
NL7900721A (nl) Nieuwe derivaten van 1-naftylazijnzuur, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze verbindingen bevatten.
NL7807679A (nl) Nieuwe benzamidinederivaten, werkwijze ter bereiding daarvan en farmaceutische preparaten, die hen bevatten.
NL7603307A (nl) Nieuwe heterocyclische verbindingen, de bereiding ervan en preparaten die deze verbindingen bevat- ten.
NL7713148A (nl) Isoxazoolderivaten, hun bereiding en deze ver- bindingen bevattende geneesmiddelen.
NL174646C (nl) 6,7-dimethoxy-4-amino-2-piperidinochinazolinen en farmaceutische preparaten die ze bevatten.